SynthesisBMC health services research2024
Assessing women's stated preferences for breast cancer screening: a systematic review and a meta-analysis.
Synthesis in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is the most common diagnosed disease, and the second leading cause of death among women. Thus, due to its importance, the current research is aimed at identifying the preferences of individuals for improving breast cancer screening programs and the related policies.
methodA systematic search was applied on databases including - PubMed, Scopus, the Web of Science, Embase, Cochrane, SID- up to October 2022. The including articles were original or review papers that assessed individuals' willingness to pay. Also, articles including the effective variables or attributes for breast cancer screening program were included. Meta-analysis was applied to calculate Willingness to Pay (WTP) as a mean for breast cancer screening followed by vote-counting for identifying the variables and attributes correlated with screening.
resultsA total of 721 articles were identified during the first phase. After the screening process, thirteen papers were chosen, out of which, nine assessed mammography as a breast cancer screening program. The results of random effect meta-analysis on the including studies indicated that the rate of willingness to pay for screening was 0.28% of GDP per capita (95%CI: 0.14-0.43), which was found to be statistically significant. The result of stratified meta- analysis indicated that the rate of willingness to pay for screening was 0.22% of GDP per capita (95%CI: 0.07-0.37), which was found to be statistically significant. Generally, income was the basic factor for receiving screening services, and cost was an effective attribute for participating in screening programs.
conclusionsTo increase women's participation in breast cancer screening programs; it is essential to provide legitimate information and eliminate the barriers to women's non-participation. Offering rapid tests at low costs in healthcare centers (both in terms of travel and screening time) delivered by female staff can lead to an increase in women's willingness to participate in breast cancer screening programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.